Found: 25
Select item for more details and to access through your institution.
Editorial: looking for patients at risk of cirrhosis in the general population—many needles in a haystack.
- Published in:
- 2018
- By:
- Publication type:
- Letter to the Editor
Editorial: weighing the global risk of cancer with thiopurines in inflammatory bowel disease—Authors' reply.
- Published in:
- 2018
- By:
- Publication type:
- Letter to the Editor
Systematic review with meta‐analysis: effectiveness and tolerability of interferon‐free direct‐acting antiviral regimens for chronic hepatitis C genotype 1 in routine clinical practice in Asia.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2018, v. 47, n. 5, p. 550, doi. 10.1111/apt.14507
- By:
- Publication type:
- Article
Letter: what gastroenterologists should know about VSL#3.
- Published in:
- 2018
- By:
- Publication type:
- Letter to the Editor
Editorial: a novel technology for the assessment of non‐alcoholic fatty liver disease.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2018, v. 47, n. 5, p. 691, doi. 10.1111/apt.14501
- By:
- Publication type:
- Article
Review article: coeliac disease in later life must not be missed.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2018, v. 47, n. 5, p. 563, doi. 10.1111/apt.14490
- By:
- Publication type:
- Article
Letter: nutritional benefits of rifaximin in cirrhotic patients.
- Published in:
- 2018
- By:
- Publication type:
- Letter to the Editor
Phenotype and natural history of elderly onset inflammatory bowel disease: a multicentre, case‐control study.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2018, v. 47, n. 5, p. 605, doi. 10.1111/apt.14494
- By:
- Publication type:
- Article
Letter: the efficacy and safety of rifaximin for the prophylaxis of spontaneous bacterial peritonitis in cirrhotic patients.
- Published in:
- 2018
- By:
- Publication type:
- Letter to the Editor
Clinical and metabolic effects associated with weight changes and obeticholic acid in non‐alcoholic steatohepatitis.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2018, v. 47, n. 5, p. 645, doi. 10.1111/apt.14492
- By:
- Publication type:
- Article
Letter: innovative use of the alfapump system to treat small hepatocellular carcinoma – authors' reply.
- Published in:
- 2018
- By:
- Publication type:
- Letter to the Editor
Non‐invasive evaluation of portal hypertension using shear‐wave elastography: analysis of two algorithms combining liver and spleen stiffness in 191 patients with cirrhosis.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2018, v. 47, n. 5, p. 621, doi. 10.1111/apt.14488
- By:
- Publication type:
- Article
Long‐term efficacy and safety of ustekinumab in 122 refractory Crohn's disease patients: a multicentre experience.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2018, v. 47, n. 5, p. 588, doi. 10.1111/apt.14487
- By:
- Publication type:
- Article
Hospice care in Medicare patients with primary liver cancer: the impact on resource utilisation and mortality.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2018, v. 47, n. 5, p. 680, doi. 10.1111/apt.14484
- By:
- Publication type:
- Article
HLA‐DQA1‐HLA‐DRB1 polymorphism is a major predictor of azathioprine‐induced pancreatitis in patients with inflammatory bowel disease.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2018, v. 47, n. 5, p. 615, doi. 10.1111/apt.14483
- By:
- Publication type:
- Article
Sofosbuvir plus daclatasvir with or without ribavirin in 551 patients with hepatitis C‐related cirrhosis, genotype 4.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2018, v. 47, n. 5, p. 674, doi. 10.1111/apt.14482
- By:
- Publication type:
- Article
Soluble CD163 and soluble mannose receptor predict survival and decompensation in patients with liver cirrhosis, and correlate with gut permeability and bacterial translocation.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2018, v. 47, n. 5, p. 657, doi. 10.1111/apt.14474
- By:
- Publication type:
- Article
Viral kinetics analysis and virological characterization of treatment failures in patients with chronic hepatitis C treated with sofosbuvir and an NS5A inhibitor.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2018, v. 47, n. 5, p. 665, doi. 10.1111/apt.14478
- By:
- Publication type:
- Article
Editorial: weighing the global risk of cancer with thiopurines in inflammatory bowel disease.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2018, v. 47, n. 5, p. 689, doi. 10.1111/apt.14475
- By:
- Publication type:
- Article
Vedolizumab in the treatment of chronic, antibiotic‐dependent or refractory pouchitis.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2018, v. 47, n. 5, p. 581, doi. 10.1111/apt.14479
- By:
- Publication type:
- Article
Utility and cost evaluation of multiparametric magnetic resonance imaging for the assessment of non‐alcoholic fatty liver disease.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2018, v. 47, n. 5, p. 631, doi. 10.1111/apt.14469
- By:
- Publication type:
- Article
Comparison of infliximab with adalimumab in 827 biologic‐naïve patients with Crohn's disease: a population‐based Danish cohort study.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2018, v. 47, n. 5, p. 596, doi. 10.1111/apt.14466
- By:
- Publication type:
- Article
Letter: innovative use of the alfapump system to treat a small hepatocellular carcinoma.
- Published in:
- 2018
- By:
- Publication type:
- Letter to the Editor
Issue Information.
- Published in:
- 2018
- Publication type:
- Table of Contents
Postoperative outcomes in vedolizumab‐treated Crohn's disease patients undergoing major abdominal operations.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2018, v. 47, n. 5, p. 573, doi. 10.1111/apt.14459
- By:
- Publication type:
- Article